FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer.
Published version of a preprint
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Tumor cells evolve by interacting with the local microenvironment; however, the tumor–stroma interactions that govern tumor metastasis are poorly understood. In this study, proteomic analyses reveal that coculture with tumor-associated fibroblasts (TAF) induces significant overexpression of FGFR4, but not other FGFRs, in colorectal cancer cell lines. Mechanistic study shows that FGFR4 plays crucial roles in TAF-induced epithelial-to-mesenchymal transition (EMT) in colorectal cancer cell lines. Accumulated FGFR4 in cell membrane phosphorylates β-catenin, leading to translocation of β-catenin into the nucleus. Further, TAF-derived CCL2 and its downstream transcription factor, Ets-1, are prerequisites for TAF-induced FGFR4 upregulation. Furthermore, FGFR4-associated pathways are shown to be preferentially activated in colorectal tumor samples, and direct tumor metastasis in a mouse metastasis model. Our study shows a pivotal role of FGFR4 in tumor–stroma interactions during colorectal cancer metastasis, and suggests novel therapeutic opportunities for the treatment of colorectal cancer. Cancer Res; 73(19); 5926–35. ©2013 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In CRC, CAF-derived CCL2 upregulates FGFR4, which plays a role in tumor-matrix interactions and promotes EMT, which may constitute an essential factor in CRC resistance to 5-FU and oxaliplatin [294].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [294]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“Multiple interactions between tumor cells and TAFs govern tumor progression, promoting the escape of tumor cells from immune-surveillance or hormonal control, and achieving the invasive phenotype required for translocation to a distant organ (4).”
BackgroundWnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583 · cited 1×
“It is known that disruption of the APC/Axin/GSK-3 complex stabilizes -catenin, which is a crucial step in the activation of Wnt signaling (13).”
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 1×
“Although TAFs are considered to be among the key determinants in the metastatic progression of cancer (8), mechanisms underlying the regulatory effect of TAFs on cancer cells are”
BackgroundCCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Self-citationFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693 · cited 9×
“FGFR4 mediates TAF-induced activation of Wnt signaling pathway via b-catenin Y142 phosphorylation Cross-talk between FGF and Wnt signaling pathways is involved in a range of biological processes, including carcinogenesis (5).”
BackgroundInfluentialThe FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945 · cited 1×
“S4B) (10), and elevated cell sensitivity to FGF19, which uniquely binds to, and signals through FGFR4 (Fig.”
BackgroundCancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
Hwang, R. F., Moore, T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A., Ji, B., Evans, D. B., & Logsdon, C. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5714 · Cited by 1,099
Leukemia cell to endothelial cell communication via exosomal miRNAs
Umezu, T., Ohyashiki, K., Kuroda, M., & Ohyashiki, J. H. (2013) · Oncogene · doi:10.1038/onc.2012.295 · Cited by 448
Tsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P., Loera, S., Luu, T., Li, A. X., Wu, X., Ye, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3567 · Cited by 407 · cited 2×
“CCL2 is highly expressed in TAFs (17), and its downstream transcription factor, Ets-1, can initiate FGFR4 expression by direct binding to FGFR4 promoter (18, 19).”
BackgroundKim, J., Takeuchi, H., Lam, S. T., Turner, R. R., Wang, H.-J., Kuo, C., Foshag, L., Bilchik, A. J., & Hoon, D. S. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.078 · Cited by 378 · cited 1×
“Colorectal cancer is one of the most frequent causes of cancer-related death worldwide (1).”
Background
Cited by
Blondy, S., David, V., Verdier, M., Mathonnet, M., Perraud, A., & Christou, N. (2020) · Cancer Science · doi:10.1111/cas.14532 · Cited by 507
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
Self-citationPark, J. H., Richards, C. H., McMillan, D. C., Horgan, P. G., & Roxburgh, C. S. D. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt593 · Cited by 219
Mo, S., Tang, P., Luo, W., Zhang, L., Li, Y., Hu, X., Ma, X., Chen, Y., Bao, Y., He, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202204097 · Cited by 198
Self-citation
Metadata
- Authors
- Liu, R., Li, J., Xie, K., Zhang, T., Lei, Y., Chen, Y., Zhang, L., Huang, K., Wang, K., Wu, H., Wu, M., Nice, E. C., Huang, C., & Wei, Y.
- Affiliations
- Chengdu Medical College (CN)
- Corresponding author
- Huang, Canhua
- ORCID
- Venue
- Cancer Research
- Published
- 2013-10-01
- Volume
- 73
- Issue
- 19
- Pages
- 5926-5935
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2170056461
- Cited by
- 104
- References
- 24
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 11 · 2023: 8 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 5 · 2018: 11 · 2017: 7 · 2016: 9 · 2015: 16 · 2014: 12 · 2013: 1
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI109317)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- FGFR4, epithelial-mesenchymal transition, colorectal cancer, tumor-stroma interactions, cancer-associated fibroblasts, tumor microenvironment, β-catenin phosphorylation, MCP-1, ETS1, metastasis, therapeutic target
- MeSH terms
- Cell Nucleus, Fibroblasts, Fluorescent Antibody Technique, Humans, Immunoenzyme Techniques, Lung Neoplasms, Phosphorylation, Blotting, Western, Colorectal Neoplasms, Signal Transduction, Cadherins, Gene Expression Regulation, Neoplastic, Stromal Cells, Apoptosis, Cell Line, Tumor, Immunoprecipitation, Cell Proliferation, Proto-Oncogene Protein c-ets-1, beta Catenin, Receptor, Fibroblast Growth Factor, Type 4, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-4718
- The paper
- Liu, R., Li, J., Xie, K., Zhang, T., Lei, Y., Chen, Y., Zhang, L., Huang, K., Wang, K., Wu, H., Wu, M., Nice, E. C., Huang, C., & Wei, Y. (2013). FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-4718
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.